Haleos Labs Limited (BOM:540679)
1,586.00
+37.00 (2.39%)
At close: Oct 6, 2026
Haleos Labs Revenue
Haleos Labs had revenue of 729.42M INR in the quarter ending June 30, 2026, a decrease of -11.59%. This brings the company's revenue in the last twelve months to 3.24B, down -3.12% year-over-year. In the fiscal year ending March 31, 2026, Haleos Labs had annual revenue of 3.34B, down -3.17%.
Revenue (ttm)
3.24B
Revenue Growth
-3.12%
P/S Ratio
1.48
Revenue / Employee
5.31M
Employees
611
Market Cap
4.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.34B | -109.29M | -3.17% |
| Mar 31, 2025 | 3.45B | 387.65M | 12.67% |
| Mar 31, 2024 | 3.06B | -96.02M | -3.04% |
| Mar 31, 2023 | 3.16B | -345.11M | -9.86% |
| Mar 31, 2022 | 3.50B | 844.79M | 31.81% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wanbury | 6.53B |
| ZIM Laboratories | 3.97B |
| Albert David | 3.64B |
| Kilitch Drugs (India) | 2.37B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 2.06B |
| Sat Kartar Life | 2.01B |
| Jenburkt Pharmaceuticals | 1.69B |